0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Viral Transduction Enhancer Market Research Report 2026
Published Date: 2026-02-26
|
Report Code: QYRE-Auto-13C18230
Home | Market Reports | Health| Medical Devices & Equipment
Global Viral Transduction Enhancer Market Research Report 2024
BUY CHAPTERS

Global Viral Transduction Enhancer Market Research Report 2026

Code: QYRE-Auto-13C18230
Report
2026-02-26
Pages:124
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Viral Transduction Enhancer Market

The global Viral Transduction Enhancer market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Viral Transduction Enhancer competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
A Viral Transduction Enhancer refers to a substance or method that increases the efficiency with which a virus introduces genetic material into a host cell. In gene therapy and research, viral transduction is a common technique used to deliver therapeutic genes or other genetic elements into cells. Enhancers in this context can include chemical compounds, modifications to the virus, or specific environmental conditions that improve the virus's ability to enter the host cell, thereby increasing the success rate of gene delivery and expression. These enhancers are crucial in optimizing the effectiveness of viral-based gene therapies and related biotechnological applications.
The North American market for Viral Transduction Enhancer is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Viral Transduction Enhancer is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Viral Transduction Enhancer include Thermo Fisher Scientific, Applied Biological Materials, Takara Bio, OZ Biosciences, Revvity, Bio-Techne, Virongy, BPS Bioscience, System Biosciences, Miltenyi Biotec, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Viral Transduction Enhancer market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Viral Transduction Enhancer. The Viral Transduction Enhancer market size, estimates, and forecasts are provided in terms of sales volume (kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Viral Transduction Enhancer market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Viral Transduction Enhancer manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Viral Transduction Enhancer Market Report

Report Metric Details
Report Name Viral Transduction Enhancer Market
Segment by Type
  • Retrovirus (RV)
  • Adenovirus (AdV)
  • Adeno-associated Virus (AAV)
by Application
  • Hospitals
  • Clinical Laboratories
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher Scientific, Applied Biological Materials, Takara Bio, OZ Biosciences, Revvity, Bio-Techne, Virongy, BPS Bioscience, System Biosciences, Miltenyi Biotec, komabiotech, ABP Biosciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Viral Transduction Enhancer manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Viral Transduction Enhancer sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Viral Transduction Enhancer Market report?

Ans: The main players in the Viral Transduction Enhancer Market are Thermo Fisher Scientific, Applied Biological Materials, Takara Bio, OZ Biosciences, Revvity, Bio-Techne, Virongy, BPS Bioscience, System Biosciences, Miltenyi Biotec, komabiotech, ABP Biosciences

What are the Application segmentation covered in the Viral Transduction Enhancer Market report?

Ans: The Applications covered in the Viral Transduction Enhancer Market report are Hospitals, Clinical Laboratories, Others

What are the Type segmentation covered in the Viral Transduction Enhancer Market report?

Ans: The Types covered in the Viral Transduction Enhancer Market report are Retrovirus (RV), Adenovirus (AdV), Adeno-associated Virus (AAV)

1 Viral Transduction Enhancer Market Overview
1.1 Product Definition
1.2 Viral Transduction Enhancer by Type
1.2.1 Global Viral Transduction Enhancer Market Value by Type: 2025 vs 2032
1.2.2 Retrovirus (RV)
1.2.3 Adenovirus (AdV)
1.2.4 Adeno-associated Virus (AAV)
1.3 Viral Transduction Enhancer by Application
1.3.1 Global Viral Transduction Enhancer Market Value by Application: 2025 vs 2032
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Others
1.4 Global Viral Transduction Enhancer Market Size Estimates and Forecasts
1.4.1 Global Viral Transduction Enhancer Revenue 2021–2032
1.4.2 Global Viral Transduction Enhancer Sales 2021–2032
1.4.3 Global Viral Transduction Enhancer Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Viral Transduction Enhancer Market Competition by Manufacturers
2.1 Global Viral Transduction Enhancer Sales Market Share by Manufacturers (2021–2026)
2.2 Global Viral Transduction Enhancer Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Viral Transduction Enhancer Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Viral Transduction Enhancer, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Viral Transduction Enhancer, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Viral Transduction Enhancer, Product Types and Applications
2.7 Global Key Manufacturers of Viral Transduction Enhancer, Date of Entry into the Industry
2.8 Global Viral Transduction Enhancer Market Competitive Situation and Trends
2.8.1 Global Viral Transduction Enhancer Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Viral Transduction Enhancer Players Market Share by Revenue
2.8.3 Global Viral Transduction Enhancer Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Viral Transduction Enhancer Market Scenario by Region
3.1 Global Viral Transduction Enhancer Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Viral Transduction Enhancer Sales by Region: 2021–2032
3.2.1 Global Viral Transduction Enhancer Sales by Region: 2021–2026
3.2.2 Global Viral Transduction Enhancer Sales by Region: 2027–2032
3.3 Global Viral Transduction Enhancer Revenue by Region: 2021–2032
3.3.1 Global Viral Transduction Enhancer Revenue by Region: 2021–2026
3.3.2 Global Viral Transduction Enhancer Revenue by Region: 2027–2032
3.4 North America Viral Transduction Enhancer Market Facts & Figures by Country
3.4.1 North America Viral Transduction Enhancer Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Viral Transduction Enhancer Sales by Country (2021–2032)
3.4.3 North America Viral Transduction Enhancer Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Viral Transduction Enhancer Market Facts & Figures by Country
3.5.1 Europe Viral Transduction Enhancer Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Viral Transduction Enhancer Sales by Country (2021–2032)
3.5.3 Europe Viral Transduction Enhancer Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Viral Transduction Enhancer Market Facts & Figures by Region
3.6.1 Asia Pacific Viral Transduction Enhancer Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Viral Transduction Enhancer Sales by Region (2021–2032)
3.6.3 Asia Pacific Viral Transduction Enhancer Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Viral Transduction Enhancer Market Facts & Figures by Country
3.7.1 Latin America Viral Transduction Enhancer Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Viral Transduction Enhancer Sales by Country (2021–2032)
3.7.3 Latin America Viral Transduction Enhancer Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Viral Transduction Enhancer Market Facts & Figures by Country
3.8.1 Middle East and Africa Viral Transduction Enhancer Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Viral Transduction Enhancer Sales by Country (2021–2032)
3.8.3 Middle East and Africa Viral Transduction Enhancer Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Viral Transduction Enhancer Sales by Type (2021–2032)
4.1.1 Global Viral Transduction Enhancer Sales by Type (2021–2026)
4.1.2 Global Viral Transduction Enhancer Sales by Type (2027–2032)
4.1.3 Global Viral Transduction Enhancer Sales Market Share by Type (2021–2032)
4.2 Global Viral Transduction Enhancer Revenue by Type (2021–2032)
4.2.1 Global Viral Transduction Enhancer Revenue by Type (2021–2026)
4.2.2 Global Viral Transduction Enhancer Revenue by Type (2027–2032)
4.2.3 Global Viral Transduction Enhancer Revenue Market Share by Type (2021–2032)
4.3 Global Viral Transduction Enhancer Price by Type (2021–2032)
5 Segment by Application
5.1 Global Viral Transduction Enhancer Sales by Application (2021–2032)
5.1.1 Global Viral Transduction Enhancer Sales by Application (2021–2026)
5.1.2 Global Viral Transduction Enhancer Sales by Application (2027–2032)
5.1.3 Global Viral Transduction Enhancer Sales Market Share by Application (2021–2032)
5.2 Global Viral Transduction Enhancer Revenue by Application (2021–2032)
5.2.1 Global Viral Transduction Enhancer Revenue by Application (2021–2026)
5.2.2 Global Viral Transduction Enhancer Revenue by Application (2027–2032)
5.2.3 Global Viral Transduction Enhancer Revenue Market Share by Application (2021–2032)
5.3 Global Viral Transduction Enhancer Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Viral Transduction Enhancer Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Thermo Fisher Scientific Viral Transduction Enhancer Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Applied Biological Materials
6.2.1 Applied Biological Materials Company Information
6.2.2 Applied Biological Materials Description and Business Overview
6.2.3 Applied Biological Materials Viral Transduction Enhancer Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Applied Biological Materials Viral Transduction Enhancer Product Portfolio
6.2.5 Applied Biological Materials Recent Developments/Updates
6.3 Takara Bio
6.3.1 Takara Bio Company Information
6.3.2 Takara Bio Description and Business Overview
6.3.3 Takara Bio Viral Transduction Enhancer Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Takara Bio Viral Transduction Enhancer Product Portfolio
6.3.5 Takara Bio Recent Developments/Updates
6.4 OZ Biosciences
6.4.1 OZ Biosciences Company Information
6.4.2 OZ Biosciences Description and Business Overview
6.4.3 OZ Biosciences Viral Transduction Enhancer Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 OZ Biosciences Viral Transduction Enhancer Product Portfolio
6.4.5 OZ Biosciences Recent Developments/Updates
6.5 Revvity
6.5.1 Revvity Company Information
6.5.2 Revvity Description and Business Overview
6.5.3 Revvity Viral Transduction Enhancer Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Revvity Viral Transduction Enhancer Product Portfolio
6.5.5 Revvity Recent Developments/Updates
6.6 Bio-Techne
6.6.1 Bio-Techne Company Information
6.6.2 Bio-Techne Description and Business Overview
6.6.3 Bio-Techne Viral Transduction Enhancer Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Bio-Techne Viral Transduction Enhancer Product Portfolio
6.6.5 Bio-Techne Recent Developments/Updates
6.7 Virongy
6.7.1 Virongy Company Information
6.7.2 Virongy Description and Business Overview
6.7.3 Virongy Viral Transduction Enhancer Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Virongy Viral Transduction Enhancer Product Portfolio
6.7.5 Virongy Recent Developments/Updates
6.8 BPS Bioscience
6.8.1 BPS Bioscience Company Information
6.8.2 BPS Bioscience Description and Business Overview
6.8.3 BPS Bioscience Viral Transduction Enhancer Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 BPS Bioscience Viral Transduction Enhancer Product Portfolio
6.8.5 BPS Bioscience Recent Developments/Updates
6.9 System Biosciences
6.9.1 System Biosciences Company Information
6.9.2 System Biosciences Description and Business Overview
6.9.3 System Biosciences Viral Transduction Enhancer Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 System Biosciences Viral Transduction Enhancer Product Portfolio
6.9.5 System Biosciences Recent Developments/Updates
6.10 Miltenyi Biotec
6.10.1 Miltenyi Biotec Company Information
6.10.2 Miltenyi Biotec Description and Business Overview
6.10.3 Miltenyi Biotec Viral Transduction Enhancer Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Miltenyi Biotec Viral Transduction Enhancer Product Portfolio
6.10.5 Miltenyi Biotec Recent Developments/Updates
6.11 komabiotech
6.11.1 komabiotech Company Information
6.11.2 komabiotech Description and Business Overview
6.11.3 komabiotech Viral Transduction Enhancer Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 komabiotech Viral Transduction Enhancer Product Portfolio
6.11.5 komabiotech Recent Developments/Updates
6.12 ABP Biosciences
6.12.1 ABP Biosciences Company Information
6.12.2 ABP Biosciences Description and Business Overview
6.12.3 ABP Biosciences Viral Transduction Enhancer Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 ABP Biosciences Viral Transduction Enhancer Product Portfolio
6.12.5 ABP Biosciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Viral Transduction Enhancer Industry Chain Analysis
7.2 Viral Transduction Enhancer Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Viral Transduction Enhancer Production Mode & Process Analysis
7.4 Viral Transduction Enhancer Sales and Marketing
7.4.1 Viral Transduction Enhancer Sales Channels
7.4.2 Viral Transduction Enhancer Distributors
7.5 Viral Transduction Enhancer Customer Analysis
8 Viral Transduction Enhancer Market Dynamics
8.1 Viral Transduction Enhancer Industry Trends
8.2 Viral Transduction Enhancer Market Drivers
8.3 Viral Transduction Enhancer Market Challenges
8.4 Viral Transduction Enhancer Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Viral Transduction Enhancer Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Viral Transduction Enhancer Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Viral Transduction Enhancer Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Viral Transduction Enhancer Sales (kg) of Key Manufacturers (2021–2026)
 Table 5. Global Viral Transduction Enhancer Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Viral Transduction Enhancer Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Viral Transduction Enhancer Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Viral Transduction Enhancer Average Price (US$/kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Viral Transduction Enhancer, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Viral Transduction Enhancer, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Viral Transduction Enhancer, Product Types and Applications
 Table 12. Global Key Manufacturers of Viral Transduction Enhancer, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Viral Transduction Enhancer Companies by Tier (Tier 1, Tier 2, Tier 3), based on Viral Transduction Enhancer Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Viral Transduction Enhancer Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Viral Transduction Enhancer Sales by Region (kg), 2021–2026
 Table 18. Global Viral Transduction Enhancer Sales Market Share by Region (2021–2026)
 Table 19. Global Viral Transduction Enhancer Sales by Region (kg), 2027–2032
 Table 20. Global Viral Transduction Enhancer Sales Market Share by Region (2027–2032)
 Table 21. Global Viral Transduction Enhancer Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Viral Transduction Enhancer Revenue Market Share by Region (2021–2026)
 Table 23. Global Viral Transduction Enhancer Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Viral Transduction Enhancer Revenue Market Share by Region (2027–2032)
 Table 25. North America Viral Transduction Enhancer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Viral Transduction Enhancer Sales by Country (kg), 2021–2026
 Table 27. North America Viral Transduction Enhancer Sales by Country (kg), 2027–2032
 Table 28. North America Viral Transduction Enhancer Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Viral Transduction Enhancer Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Viral Transduction Enhancer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Viral Transduction Enhancer Sales by Country (kg), 2021–2026
 Table 32. Europe Viral Transduction Enhancer Sales by Country (kg), 2027–2032
 Table 33. Europe Viral Transduction Enhancer Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Viral Transduction Enhancer Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Viral Transduction Enhancer Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Viral Transduction Enhancer Sales by Region (kg), 2021–2026
 Table 37. Asia Pacific Viral Transduction Enhancer Sales by Region (kg), 2027–2032
 Table 38. Asia Pacific Viral Transduction Enhancer Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Viral Transduction Enhancer Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Viral Transduction Enhancer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Viral Transduction Enhancer Sales by Country (kg), 2021–2026
 Table 42. Latin America Viral Transduction Enhancer Sales by Country (kg), 2027–2032
 Table 43. Latin America Viral Transduction Enhancer Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Viral Transduction Enhancer Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Viral Transduction Enhancer Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Viral Transduction Enhancer Sales by Country (kg), 2021–2026
 Table 47. Middle East and Africa Viral Transduction Enhancer Sales by Country (kg), 2027–2032
 Table 48. Middle East and Africa Viral Transduction Enhancer Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Viral Transduction Enhancer Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Viral Transduction Enhancer Sales (kg) by Type (2021–2026)
 Table 51. Global Viral Transduction Enhancer Sales (kg) by Type (2027–2032)
 Table 52. Global Viral Transduction Enhancer Sales Market Share by Type (2021–2026)
 Table 53. Global Viral Transduction Enhancer Sales Market Share by Type (2027–2032)
 Table 54. Global Viral Transduction Enhancer Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Viral Transduction Enhancer Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Viral Transduction Enhancer Revenue Market Share by Type (2021–2026)
 Table 57. Global Viral Transduction Enhancer Revenue Market Share by Type (2027–2032)
 Table 58. Global Viral Transduction Enhancer Price (US$/kg) by Type (2021–2026)
 Table 59. Global Viral Transduction Enhancer Price (US$/kg) by Type (2027–2032)
 Table 60. Global Viral Transduction Enhancer Sales (kg) by Application (2021–2026)
 Table 61. Global Viral Transduction Enhancer Sales (kg) by Application (2027–2032)
 Table 62. Global Viral Transduction Enhancer Sales Market Share by Application (2021–2026)
 Table 63. Global Viral Transduction Enhancer Sales Market Share by Application (2027–2032)
 Table 64. Global Viral Transduction Enhancer Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Viral Transduction Enhancer Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Viral Transduction Enhancer Revenue Market Share by Application (2021–2026)
 Table 67. Global Viral Transduction Enhancer Revenue Market Share by Application (2027–2032)
 Table 68. Global Viral Transduction Enhancer Price (US$/kg) by Application (2021–2026)
 Table 69. Global Viral Transduction Enhancer Price (US$/kg) by Application (2027–2032)
 Table 70. Thermo Fisher Scientific Company Information
 Table 71. Thermo Fisher Scientific Description and Business Overview
 Table 72. Thermo Fisher Scientific Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 73. Thermo Fisher Scientific Viral Transduction Enhancer Product
 Table 74. Thermo Fisher Scientific Recent Developments/Updates
 Table 75. Applied Biological Materials Company Information
 Table 76. Applied Biological Materials Description and Business Overview
 Table 77. Applied Biological Materials Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 78. Applied Biological Materials Viral Transduction Enhancer Product
 Table 79. Applied Biological Materials Recent Developments/Updates
 Table 80. Takara Bio Company Information
 Table 81. Takara Bio Description and Business Overview
 Table 82. Takara Bio Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 83. Takara Bio Viral Transduction Enhancer Product
 Table 84. Takara Bio Recent Developments/Updates
 Table 85. OZ Biosciences Company Information
 Table 86. OZ Biosciences Description and Business Overview
 Table 87. OZ Biosciences Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 88. OZ Biosciences Viral Transduction Enhancer Product
 Table 89. OZ Biosciences Recent Developments/Updates
 Table 90. Revvity Company Information
 Table 91. Revvity Description and Business Overview
 Table 92. Revvity Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 93. Revvity Viral Transduction Enhancer Product
 Table 94. Revvity Recent Developments/Updates
 Table 95. Bio-Techne Company Information
 Table 96. Bio-Techne Description and Business Overview
 Table 97. Bio-Techne Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 98. Bio-Techne Viral Transduction Enhancer Product
 Table 99. Bio-Techne Recent Developments/Updates
 Table 100. Virongy Company Information
 Table 101. Virongy Description and Business Overview
 Table 102. Virongy Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 103. Virongy Viral Transduction Enhancer Product
 Table 104. Virongy Recent Developments/Updates
 Table 105. BPS Bioscience Company Information
 Table 106. BPS Bioscience Description and Business Overview
 Table 107. BPS Bioscience Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 108. BPS Bioscience Viral Transduction Enhancer Product
 Table 109. BPS Bioscience Recent Developments/Updates
 Table 110. System Biosciences Company Information
 Table 111. System Biosciences Description and Business Overview
 Table 112. System Biosciences Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 113. System Biosciences Viral Transduction Enhancer Product
 Table 114. System Biosciences Recent Developments/Updates
 Table 115. Miltenyi Biotec Company Information
 Table 116. Miltenyi Biotec Description and Business Overview
 Table 117. Miltenyi Biotec Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 118. Miltenyi Biotec Viral Transduction Enhancer Product
 Table 119. Miltenyi Biotec Recent Developments/Updates
 Table 120. komabiotech Company Information
 Table 121. komabiotech Description and Business Overview
 Table 122. komabiotech Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 123. komabiotech Viral Transduction Enhancer Product
 Table 124. komabiotech Recent Developments/Updates
 Table 125. ABP Biosciences Company Information
 Table 126. ABP Biosciences Description and Business Overview
 Table 127. ABP Biosciences Viral Transduction Enhancer Sales (kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 128. ABP Biosciences Viral Transduction Enhancer Product
 Table 129. ABP Biosciences Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Viral Transduction Enhancer Distributors List
 Table 133. Viral Transduction Enhancer Customers List
 Table 134. Viral Transduction Enhancer Market Trends
 Table 135. Viral Transduction Enhancer Market Drivers
 Table 136. Viral Transduction Enhancer Market Challenges
 Table 137. Viral Transduction Enhancer Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Viral Transduction Enhancer
 Figure 2. Global Viral Transduction Enhancer Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Viral Transduction Enhancer Market Share by Type: 2025 & 2032
 Figure 4. Retrovirus (RV) Product Picture
 Figure 5. Adenovirus (AdV) Product Picture
 Figure 6. Adeno-associated Virus (AAV) Product Picture
 Figure 7. Global Viral Transduction Enhancer Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Viral Transduction Enhancer Market Share by Application: 2025 & 2032
 Figure 9. Hospitals
 Figure 10. Clinical Laboratories
 Figure 11. Others
 Figure 12. Global Viral Transduction Enhancer Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Viral Transduction Enhancer Market Size (US$ Million), 2021–2032
 Figure 14. Global Viral Transduction Enhancer Sales (kg), 2021–2032
 Figure 15. Global Viral Transduction Enhancer Average Price (US$/kg), 2021–2032
 Figure 16. Viral Transduction Enhancer Report Years Considered
 Figure 17. Viral Transduction Enhancer Sales Share by Manufacturers in 2025
 Figure 18. Global Viral Transduction Enhancer Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Viral Transduction Enhancer Players: Market Share by Revenue in Viral Transduction Enhancer in 2025
 Figure 20. Viral Transduction Enhancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Viral Transduction Enhancer Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Viral Transduction Enhancer Sales Market Share by Country (2021–2032)
 Figure 23. North America Viral Transduction Enhancer Revenue Market Share by Country (2021–2032)
 Figure 24. United States Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Viral Transduction Enhancer Sales Market Share by Country (2021–2032)
 Figure 27. Europe Viral Transduction Enhancer Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Viral Transduction Enhancer Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Viral Transduction Enhancer Revenue Market Share by Region (2021–2032)
 Figure 35. China Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Viral Transduction Enhancer Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Viral Transduction Enhancer Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Viral Transduction Enhancer Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Viral Transduction Enhancer Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Viral Transduction Enhancer Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Viral Transduction Enhancer by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Viral Transduction Enhancer by Type (2021–2032)
 Figure 55. Global Viral Transduction Enhancer Price (US$/kg) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Viral Transduction Enhancer by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Viral Transduction Enhancer by Application (2021–2032)
 Figure 58. Global Viral Transduction Enhancer Price (US$/kg) by Application (2021–2032)
 Figure 59. Viral Transduction Enhancer Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India